Table 3 Univariate and multivariate analyses of associations between various parameters and overall survival.
From: Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.03 | 1.00–1.06 | 0.01 | 1.03 | 0.99–1.06 | 0.06 |
Male | 0.98 | 0.56–1.70 | 0.95 | |||
≥ ECOG PS 1 | 2.74 | 1.61–4.65 | < 0.01 | 1.91 | 1.04–3.49 | 0.03 |
CCI 1 or more | 1.59 | 1.02–2.48 | 0.04 | 1.25 | 0.79–1.98 | 0.33 |
Psoas muscle index | 0.82 | 0.69–0.96 | 0.02 | 0.87 | 0.73–1.03 | 0.11 |
Average psoas muscle density | 0.96 | 0.94–0.99 | 0.01 | 0.98 | 0.95–1.00 | 0.18 |
Neoadjuvant chemotherapy | 0.97 | 0.59–1.59 | 0.90 | |||
non UC (vs UC) | 2.77 | 1.48–5.18 | < 0.01 | 1.72 | 0.89–3.34 | 0.10 |
≥ pT3 | 3.63 | 2.31–5.71 | < 0.01 | 2.72 | 1.65–4.48 | < 0.01 |
pN positivity | 2.29 | 1.38–3.79 | < 0.01 | 2.27 | 1.30–3.96 | < 0.01 |
Concurrent CIS | 0.85 | 0.48–1.49 | 0.58 | |||
